MIR Fundamental Analysis - MEDMIRA INC

Fundamental Rating

Taking everything into account, MIR scores 0 out of 10 in our fundamental rating. MIR was compared to 15 industry peers in the Health Care Equipment & Supplies industry. MIR may be in some trouble as it scores bad on both profitability and health. MIR does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

MIR had negative earnings in the past year.

MIR had a negative operating cash flow in the past year.

MIR had negative earnings in each of the past 5 years.

MIR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

MIR's Return On Assets of -123.38% is in line compared to the rest of the industry. MIR outperforms 60.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-123.38%
ROE	N/A
ROIC	N/A

ROA(3y)-58.63%

ROA(5y)-50.7%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 70.31%, MIR belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.

In the last couple of years the Gross Margin of MIR has declined.

MIR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	70.31%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-11.9%

GM growth 5Y-7.32%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for MIR has been increased compared to 1 year ago.

MIR has more shares outstanding than it did 5 years ago.

The debt/assets ratio for MIR has been reduced compared to a year ago.

2.2 Solvency

MIR has an Altman-Z score of -41.68. This is a bad value and indicates that MIR is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -41.68, MIR is doing worse than 66.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-41.68

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.07 indicates that MIR may have some problems paying its short term obligations.

The Current ratio of MIR (0.07) is worse than 93.33% of its industry peers.

MIR has a Quick Ratio of 0.07. This is a bad value and indicates that MIR is not financially healthy enough and could expect problems in meeting its short term obligations.

MIR has a Quick ratio of 0.06. This is amonst the worse of the industry: MIR underperforms 86.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.07
Quick Ratio	0.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MIR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.27%.

The Revenue for MIR has decreased by -33.67% in the past year. This is quite bad

Measured over the past years, MIR shows a decrease in Revenue. The Revenue has been decreasing by -4.79% on average per year.

EPS 1Y (TTM)-52.27%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-27.27%

Revenue 1Y (TTM)-33.67%

Revenue growth 3Y-42.27%

Revenue growth 5Y-4.79%

Sales Q2Q%-27.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MIR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MIR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MEDMIRA INC

TSX-V:MIR (7/16/2025, 7:00:00 PM)

0.075

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)07-02 2025-07-02

Earnings (Next)11-26 2025-11-26

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners0.37%

Ins Owner ChangeN/A

Market Cap56.87M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	223.65
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFYN/A

OCF(TTM)0

OCFYN/A

SpS0

BVpS-0.03

TBVpS-0.03

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-123.38%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	70.31%
FCFM	N/A

ROA(3y)-58.63%

ROA(5y)-50.7%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-11.9%

GM growth 5Y-7.32%

F-Score3

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.07
Quick Ratio	0.06
Altman-Z	-41.68

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-52.27%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-27.27%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-33.67%

Revenue growth 3Y-42.27%

Revenue growth 5Y-4.79%

Sales Q2Q%-27.57%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-73.64%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-259.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-287.13%

OCF growth 3YN/A

OCF growth 5YN/A

MEDMIRA INC (MIR.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens